Skip to main content

Table 2 Clinical characteristics of the patients who underwent angioplasty from March 2009 to March 2012 in Hamadan (west of Iran)

From: Risk factors associated with major adverse cardiac and cerebrovascular events following percutaneous coronary intervention: a 10-year follow-up comparing random survival forest and Cox proportional-hazards model

Variable

N

%

Restricted mean ± SE

Median

P value*

All

220

100

   

Age (years)

60.00 ± 11.09

    

Sex

    

0.903

 Female

69

31.4

95.01 ± 3.96

104.00

 

 Male

151

68.6

96.66 ± 2.78

108.00

 

Smoking

    

< 0.001

 No

63

28.6

102.19 ± 2.52

112.00

 

 Yes

157

71.4

81.25 ± 4.19

93.00

 

Diabetes

    

< 0.001

 No

40

18.2

101.74 ± 2.41

114.00

 

 Yes

180

81.8

73.73 ± 2.85

82.00

 

Hypertension

    

0.029

 No

86

39.1

100.38 ± 2.95

114.00

 

 Yes

134

60.9

90.74 ± 3.45

102.00

 

Hyperlipidemia

    

0.089

 No

56

25.5

97.98 ± 2.71

109.00

 

 Yes

164

74.5

91.33 ± 4.17

96.00

 

Stent length

    

0.006

 ≤ 20 mm

141

64.1

98.36 ± 2.64

-

 

 > 20 mm

79

35.9

89.79 ± 3.69

102.00

 

Stent diameter

    

0.992

 3 mm

111

50.5

96.41 ± 3.15

108.00

 

 3.5 mm

87

39.5

96.15 ± 3.53

108.00

 

 4 mm

22

10

89.68 ± 6.68

103.00

 

Number of vessels

    

0.199

 1

120

54.5

98.94 ± 3.09

108.00

 

 2

69

31.4

93.02 ± 3.83

103.00

 

 3

30

13.6

86.57 ± 4.91

86.00

 

Type of stent

    

0.752

 BMS

142

64.5

94.95 ± 3.61

103.00

 

 DES

78

35.5

96.92 ± 2.907

109.00

 

Number of stents

    

0.052

 1

152

69.1

95.85 ± 2.68

108.00

 

 2

56

25.5

98.87 ± 4.52

108.00

 

 3

12

5.5

81.75 ± 5.80

82.00

 

PCI

    

0.548

 Ad hoc

112

50.9

97.62 ± 3.28

112.00

 

 Elective

108

49.1

92.34 ± 2.74

104.00

 

Setting

    

0.26

 ACS

144

65.5

95.09 ± 2.86

105.00

 

 CSA

76

34.5

97.11 ± 3.58

114.00

 
  1. *Estimation is limited to the longest survival time if it is censored
  2. **Based on the Log rank Test